Aubrey Haddach Appointed Co-Chair of ABA’s Biotechnology Law Committee

August 2, 2018News Releases

Dinsmore & Shohl LLP attorney Aubrey Haddach has been appointed to serve another term as co-chair of the American Bar Association’s Biotechnology Law Committee for the 2018-2019 bar year. Haddach was first appointed to the leadership position last year after serving as vice-chair for the 2016-2017 bar year.

With more than 400,000 members, the American Bar Association is one of the largest voluntary professional membership organizations in the world. The Biotechnology Law Committee, part of the ABA Section of Science & Technology, keeps the public informed on an array of topics relating to biotechnology, including research, regulatory, patent, and clinical medicine issues. Throughout the year, the committee identifies important policies issues and writes articles for the SciTech Lawyer and Jurimetrics Journal. Its members also respond to requests for input on resolutions relevant to their specialties. 

“I’m honored to be able to continue leading the Biotechnology Law Committee and help better serve the public’s understanding of science and technology law,” said Haddach. “With rapid changes in technology and security on the horizon, the upcoming bar year will both exciting and rewarding.”

Haddach, a member of Dinsmore’s Intellectual Property Department, represents clients ranging from small businesses to Fortune 500 companies. She has experience in all aspects of patent law and related business matters in the U.S. and around the world. She began her career in the labs of biotech and pharmaceutical companies, having worked as both a medicinal and process research chemist.